ALEMBIC PHARMACEUTICALS
|
ALEMBIC PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹39 Cr | ₹39 Cr | ₹39 Cr | ₹39 Cr | ₹39 Cr |
| Equity - Authorised | ₹41 Cr | ₹41 Cr | ₹41 Cr | ₹41 Cr | ₹41 Cr |
| Equity - Issued | ₹39 Cr | ₹39 Cr | ₹39 Cr | ₹39 Cr | ₹39 Cr |
| Equity Paid Up | ₹39 Cr | ₹39 Cr | ₹39 Cr | ₹39 Cr | ₹39 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
| Share Warrants & Outstandings | - | - | - | - | - |
| Total Reserves | ₹5,636 Cr | ₹5,152 Cr | ₹4,779 Cr | ₹4,331 Cr | ₹5,198 Cr |
| Securities Premium | ₹748 Cr | ₹748 Cr | ₹748 Cr | ₹748 Cr | ₹748 Cr |
| Capital Reserves | - | - | - | - | - |
| Profit & Loss Account Balance | ₹4,854 Cr | ₹4,394 Cr | ₹4,027 Cr | ₹3,568 Cr | ₹2,554 Cr |
| General Reserves | ₹0.24 Cr | ₹0.24 Cr | ₹0.24 Cr | ₹0.24 Cr | ₹1,845 Cr |
| Other Reserves | ₹33 Cr | ₹8.79 Cr | ₹3.25 Cr | ₹14 Cr | ₹51 Cr |
| Reserve excluding Revaluation Reserve | ₹5,636 Cr | ₹5,152 Cr | ₹4,779 Cr | ₹4,331 Cr | ₹5,198 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹5,675 Cr | ₹5,191 Cr | ₹4,818 Cr | ₹4,370 Cr | ₹5,238 Cr |
| Minority Interest | ₹-5.83 Cr | ₹-1.42 Cr | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | - | - | - | - |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | - | - | - |
| Unsecured Loans | ₹122 Cr | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | ₹122 Cr | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹-270 Cr | ₹-166 Cr | ₹-170 Cr | ₹-123 Cr | ₹-5.89 Cr |
| Deferred Tax Assets | ₹351 Cr | ₹306 Cr | ₹301 Cr | ₹206 Cr | ₹204 Cr |
| Deferred Tax Liability | ₹82 Cr | ₹140 Cr | ₹131 Cr | ₹83 Cr | ₹198 Cr |
| Other Long Term Liabilities | ₹225 Cr | ₹47 Cr | ₹63 Cr | ₹69 Cr | ₹72 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹153 Cr | ₹124 Cr | ₹110 Cr | ₹106 Cr | ₹96 Cr |
| Total Non-Current Liabilities | ₹230 Cr | ₹5.05 Cr | ₹2.75 Cr | ₹52 Cr | ₹162 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹835 Cr | ₹880 Cr | ₹736 Cr | ₹680 Cr | ₹706 Cr |
| Sundry Creditors | ₹835 Cr | ₹880 Cr | ₹736 Cr | ₹680 Cr | ₹706 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹394 Cr | ₹232 Cr | ₹224 Cr | ₹251 Cr | ₹517 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹17 Cr | ₹17 Cr | ₹16 Cr | ₹40 Cr | ₹69 Cr |
| Interest Accrued But Not Due | ₹1.93 Cr | ₹1.35 Cr | ₹0.88 Cr | ₹0.27 Cr | ₹5.38 Cr |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | ₹200 Cr |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹376 Cr | ₹213 Cr | ₹207 Cr | ₹211 Cr | ₹242 Cr |
| Short Term Borrowings | ₹1,219 Cr | ₹1,196 Cr | ₹430 Cr | ₹636 Cr | ₹430 Cr |
| Secured ST Loans repayable on Demands | ₹219 Cr | ₹118 Cr | ₹100 Cr | ₹165 Cr | - |
| Working Capital Loans- Sec | ₹219 Cr | ₹118 Cr | ₹100 Cr | ₹165 Cr | - |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹780 Cr | ₹960 Cr | ₹230 Cr | ₹306 Cr | ₹430 Cr |
| Short Term Provisions | ₹239 Cr | ₹207 Cr | ₹131 Cr | ₹74 Cr | ₹178 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹128 Cr | ₹121 Cr | ₹65 Cr | ₹3.87 Cr | ₹114 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹111 Cr | ₹86 Cr | ₹65 Cr | ₹70 Cr | ₹64 Cr |
| Total Current Liabilities | ₹2,687 Cr | ₹2,514 Cr | ₹1,520 Cr | ₹1,641 Cr | ₹1,831 Cr |
| Total Liabilities | ₹8,586 Cr | ₹7,709 Cr | ₹6,341 Cr | ₹6,064 Cr | ₹7,230 Cr |
| ASSETS | |||||
| Gross Block | ₹4,897 Cr | ₹4,117 Cr | ₹3,875 Cr | ₹3,468 Cr | ₹2,840 Cr |
| Less: Accumulated Depreciation | ₹1,816 Cr | ₹1,594 Cr | ₹1,329 Cr | ₹1,069 Cr | ₹1,042 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹3,081 Cr | ₹2,524 Cr | ₹2,547 Cr | ₹2,398 Cr | ₹1,798 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹634 Cr | ₹837 Cr | ₹524 Cr | ₹601 Cr | ₹2,206 Cr |
| Non Current Investments | ₹141 Cr | ₹127 Cr | ₹93 Cr | ₹96 Cr | ₹118 Cr |
| Long Term Investment | ₹141 Cr | ₹127 Cr | ₹93 Cr | ₹96 Cr | ₹118 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | ₹178 Cr | ₹164 Cr | ₹130 Cr | ₹133 Cr | ₹155 Cr |
| Long Term Loans & Advances | ₹15 Cr | ₹31 Cr | ₹33 Cr | ₹54 Cr | ₹35 Cr |
| Other Non Current Assets | - | - | - | - | - |
| Total Non-Current Assets | ₹3,920 Cr | ₹3,519 Cr | ₹3,197 Cr | ₹3,150 Cr | ₹4,255 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Inventories | ₹2,511 Cr | ₹2,288 Cr | ₹1,644 Cr | ₹1,475 Cr | ₹1,610 Cr |
| Raw Materials | ₹604 Cr | ₹628 Cr | ₹386 Cr | ₹390 Cr | ₹456 Cr |
| Work-in Progress | ₹120 Cr | ₹125 Cr | ₹70 Cr | ₹75 Cr | ₹89 Cr |
| Finished Goods | ₹1,390 Cr | ₹1,113 Cr | ₹886 Cr | ₹796 Cr | ₹852 Cr |
| Packing Materials | ₹166 Cr | ₹199 Cr | ₹94 Cr | ₹69 Cr | ₹61 Cr |
| Stores  and Spare | ₹58 Cr | ₹49 Cr | ₹42 Cr | ₹38 Cr | ₹36 Cr |
| Other Inventory | ₹173 Cr | ₹174 Cr | ₹166 Cr | ₹108 Cr | ₹117 Cr |
| Sundry Debtors | ₹1,466 Cr | ₹1,400 Cr | ₹1,025 Cr | ₹1,046 Cr | ₹807 Cr |
| Debtors more than Six months | ₹5.84 Cr | ₹16 Cr | ₹27 Cr | ₹23 Cr | ₹22 Cr |
| Debtors Others | ₹1,499 Cr | ₹1,419 Cr | ₹1,033 Cr | ₹1,052 Cr | ₹819 Cr |
| Cash and Bank | ₹203 Cr | ₹90 Cr | ₹127 Cr | ₹82 Cr | ₹69 Cr |
| Cash in hand | ₹0.28 Cr | ₹0.46 Cr | ₹1.04 Cr | ₹0.28 Cr | ₹0.38 Cr |
| Balances at Bank | ₹202 Cr | ₹90 Cr | ₹126 Cr | ₹82 Cr | ₹69 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹81 Cr | ₹69 Cr | ₹60 Cr | ₹55 Cr | ₹52 Cr |
| Interest accrued on Investments | - | - | - | - | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹81 Cr | ₹69 Cr | ₹50 Cr | ₹55 Cr | ₹37 Cr |
| Other current_assets | - | - | ₹9.81 Cr | - | ₹15 Cr |
| Short Term Loans and Advances | ₹375 Cr | ₹343 Cr | ₹289 Cr | ₹255 Cr | ₹437 Cr |
| Advances recoverable in cash or in kind | ₹59 Cr | ₹50 Cr | ₹65 Cr | ₹58 Cr | ₹56 Cr |
| Advance income tax and TDS | ₹104 Cr | ₹113 Cr | ₹106 Cr | ₹87 Cr | ₹139 Cr |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹212 Cr | ₹179 Cr | ₹118 Cr | ₹110 Cr | ₹241 Cr |
| Total Current Assets | ₹4,636 Cr | ₹4,190 Cr | ₹3,144 Cr | ₹2,914 Cr | ₹2,975 Cr |
| Net Current Assets (Including Current Investments) | ₹1,949 Cr | ₹1,675 Cr | ₹1,624 Cr | ₹1,273 Cr | ₹1,144 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹8,586 Cr | ₹7,709 Cr | ₹6,341 Cr | ₹6,064 Cr | ₹7,230 Cr |
| Contingent Liabilities | ₹160 Cr | ₹69 Cr | ₹55 Cr | ₹109 Cr | ₹63 Cr |
| Total Debt | ₹1,361 Cr | ₹1,196 Cr | ₹430 Cr | ₹636 Cr | ₹630 Cr |
| Book Value | 288.72 | 264.10 | 245.14 | 222.36 | 266.47 |
| Adjusted Book Value | 288.72 | 264.10 | 245.14 | 222.36 | 266.47 |
Compare Balance Sheet of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹16,713.0 Cr | 4.1% | 15.1% | -17.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | 4.1% |
15.1% |
-17.9% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses